Source:http://linkedlifedata.com/resource/pubmed/id/12437518
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-19
|
| pubmed:abstractText |
The risk of transmission of blood-borne pathogens by transfusion is a persistent problem in medicine. To address this safety issue, INACTINE PEN110 chemistry is being utilized to develop a process for preparing pathogen-reduced red blood cell concentrates (RBCC). The purpose of this study was to characterize the virucidal effectiveness of the INACTINE PEN110 chemistry in full units of RBCC by using a panel of viruses with diverse properties in composition, size and shape.
|
| pubmed:language |
eng
|
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
313-23
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:articleTitle |
Broad-spectrum virus reduction in red cell concentrates using INACTINE PEN110 chemistry.
|
| pubmed:affiliation |
V. I. Technologies, Inc., 134 Coolidge Avenue, Watertown, MA 02472, USA. aris.lazo@vitechnologies.com
|